5-methylcytosine and 5-hydroxymethylcytosine are synergistic biomarkers for early detection of colorectal cancer. [PDF]
Puddu F +16 more
europepmc +1 more source
Profiling of 5-hydroxymethylcytosine in blood reveals preferential enrichment at exon-intron junctions and predictive value for Parkinson's disease. [PDF]
Antczak P +5 more
europepmc +1 more source
5-Hydroxymethylcytosine: a key epigenetic mark in cancer and chemotherapy response. [PDF]
Kharat SS, Sharan SK.
europepmc +1 more source
Reduced 5-hydroxymethylcytosine due to TET2 downregulation is associated with chondrosarcoma progression. [PDF]
Furukawa H +7 more
europepmc +1 more source
5-hydroxymethylcytosine profiles in circulating cell-free DNA associate with disease status in patients with osteosarcoma. [PDF]
Neczypor EW +9 more
europepmc +1 more source
Plasma cell-free DNA 5-hydroxymethylcytosine signatures as predictive biomarkers for platinum resistance and prognosis in epithelial ovarian cancer. [PDF]
Xue Y +14 more
europepmc +1 more source
Mammalian Proteome Profiling Reveals Readers and Antireaders of Strand-Symmetric and -Asymmetric 5-Hydroxymethylcytosine-Modifications in DNA. [PDF]
Engelhard L +8 more
europepmc +1 more source
5-Hydroxymethylcytosine profiles in circulating cell-free DNA serve as potential biomarkers for diagnosis and classification of adenomyosis. [PDF]
Zhang L +7 more
europepmc +1 more source
Brain-derived 5-hydroxymethylcytosine epigenetic scores are related to Alzheimer's disease pathology and cognitive decline. [PDF]
Zhang Z +9 more
europepmc +1 more source

